Clinical Trial Update: Randomized, Double-blind, Placebo-Controlled, Efficacy Study of a New Formulation of Phenylephrine HCL in the Common Cold [Phase 2]

View source ↗

Summary

Phase 2 randomized, double-blind trial evaluating a new formulation of phenylephrine HCL for the common cold; study terminated with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Cold

Drugs mentioned

• Phenylephrine HCl (phenylephrine)

Snippet

Sponsor: Johnson & Johnson Consumer Inc. (J&JCI) | Conditions: Common Cold | Phase 2 | Status: TERMINATED | Results posted: 2019-06-04